Literature DB >> 21553049

Inhibition of high glucose-induced VEGF and ICAM-1 expression in human retinal pigment epithelium cells by targeting ILK with small interference RNA.

Wei Wang1, Makoto Matsukura, Isao Fujii, Kaori Ito, Ji En Zhao, Makoto Shinohara, Ye Qing Wang, Xiao Mei Zhang.   

Abstract

The aim of this study was to investigate the change of Integrin-linked kinase (ILK) expression of human retinal pigment epithelium (RPE) cells in response to high glucose, and the effect of targeting ILK with small interference RNA (siRNA) on the high glucose-induced expression of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule-1 (ICAM-1). The ILK mRNA and protein expression in human RPE cells were analyzed with RT-PCR and western blot after exposure to 5.5, 30, 40, 50 mM glucose, or 5.5 mM glucose+45.5 mM mannitol for 48 h. The expression of VEGF and ICAM-1 was also determined. Cells were treated with ILK siRNA, to determine the effect of ILK on VEGF and ICAM-1 expression following treatment with high glucose. High concentrations of glucose significantly up-regulated ILK mRNA and protein expression, and the ILK expression increased along with the glucose concentration. The changes of VEGF and ICAM-1 expression were similar to that of ILK expression. Knocking down ILK gene expression with siRNA inhibited the elevation of VEGF and ICAM-1 induced by high glucose treatment. These results suggested that ILK was involved in the response of RPE cells to high glucose and may therefore play a role in the pathogenesis of diabetic ophthalmology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553049     DOI: 10.1007/s11033-011-0778-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.

Authors:  Maher N Younes; Orhan G Yigitbasi; Yasemin D Yazici; Samar A Jasser; Cora D Bucana; Adel K El-Naggar; Gordon B Mills; Jeffrey N Myers
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-01

2.  Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.

Authors:  Dimpy Koul; Ruijun Shen; Sherry Bergh; Yiling Lu; John F de Groot; Ta Jen Liu; Gordon B Mills; W K Alfred Yung
Journal:  Mol Cancer Ther       Date:  2005-11       Impact factor: 6.261

3.  Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase.

Authors:  Hyun-Jai Cho; Seock-Won Youn; Soo-In Cheon; Tae-Youn Kim; Jin Hur; Shu-Ying Zhang; Seung Pyo Lee; Kyung-Woo Park; Myoung-Mook Lee; Yun-Shik Choi; Young-Bae Park; Hyo-Soo Kim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-31       Impact factor: 8.311

Review 4.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

Authors:  Gregory Hannigan; Armelle A Troussard; Shoukat Dedhar
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

5.  Elevation of monocyte-derived microparticles in patients with diabetic retinopathy.

Authors:  Nahoko Ogata; Shosaku Nomura; Akira Shouzu; Masahito Imaizumi; Miwa Arichi; Miyo Matsumura
Journal:  Diabetes Res Clin Pract       Date:  2006-04-03       Impact factor: 5.602

6.  Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression.

Authors:  Kang Wang; Yanling Wang; Lixin Gao; Xinmin Li; Mingming Li; Jianyou Guo
Journal:  Biol Pharm Bull       Date:  2008-08       Impact factor: 2.233

7.  Permeability of the blood-ocular barrier in adolescent and adult diabetic patients.

Authors:  A Yoshida; S Ishiko; M Kojima; H Ogasawara
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

8.  K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Authors:  Mojca Globocnik Petrovic; Josko Osredkar; Mirna Saraga-Babić; Daniel Petrovic
Journal:  Clin Exp Ophthalmol       Date:  2008-07       Impact factor: 4.207

9.  Regulation of tumor angiogenesis by integrin-linked kinase (ILK).

Authors:  Clara Tan; Severine Cruet-Hennequart; Armelle Troussard; Ladan Fazli; Penny Costello; Kym Sutton; Jeff Wheeler; Martin Gleave; Jasbinder Sanghera; Shoukat Dedhar
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

Review 10.  Inflammatory mechanisms of diabetic complications.

Authors:  Michael D Williams; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

View more
  4 in total

1.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

2.  Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema.

Authors:  Selina Beasley; Mohamed El-Sherbiny; Sylvia Megyerdi; Sally El-Shafey; Karishma Choksi; Ismail Kaddour-Djebbar; Nader Sheibani; Stephen Hsu; Mohamed Al-Shabrawey
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

3.  Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model.

Authors:  Mehmet Tuzcu; Cemal Orhan; Omer Ersin Muz; Nurhan Sahin; Vijaya Juturu; Kazım Sahin
Journal:  BMC Ophthalmol       Date:  2017-07-24       Impact factor: 2.209

Review 4.  Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets.

Authors:  Sher Zaman Safi; Rajes Qvist; Selva Kumar; Kalaivani Batumalaie; Ikram Shah Bin Ismail
Journal:  Biomed Res Int       Date:  2014-07-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.